Sanbo Laboratory.
Here, a spirit of emerging vitality pervades, with no whiskey or floor-to-ceiling windows, only youthful faces busy in lab coats.
The equipment lock-out affects only Yang Ping's new project, but ongoing stem cell research and tumor treatment projects are also impacted.
However, this is nothing; Yang Ping had long foreseen today, just didn't expect it to come so suddenly. A sudden change is better: prolonging the agony isn't as favorable as ending illusions quickly.
In designing the project research path and experiment tools, he had considered future compatibility with domestic equipment. Thus, now switching to domestic equipment, the original research can continue unaffected.
The laboratory layout has been readjusted, and new domestic equipment has replaced imported ones.
The original imported advanced equipment has been dismantled and moved into storage as they are completely unusable.
These new devices come from several top domestic instrument manufacturers. Their appearance may not be as sleek as international top brands, some even sporting a simple industrial style, but they are usable by us. International top brands may not allow usage, so no matter how pretty, they aren't ours.
More importantly, their cores and control software are researched by Wall-breaking Alliance enterprises. The control software connects these devices together, no longer isolated piles of high-tech instruments but an embryonic, organically interactive system. To some extent, the system can compensate for the shortcomings of individual performance.
"Real-time data feedback is normal, carrier expression levels are stable within the expected range, with fluctuation under three percent." A young researcher closely watches the data stream on the screen, his voice filled with irrepressible excitement and relief.
Yang Ping stands behind him, his gaze calmly sweeping over each parameter curve, nodding slightly. This new technology platform has undergone multiple full-process, high-load pressure tests, and the results have been satisfactory.
The new platform integrates a series of key technologies and domestic core equipment from intelligent genetic sequence design, efficient carrier construction, to large-scale cell culture and precise function validation.
"The data throughput and backend analysis algorithm efficiency of the platform still have gaps compared to our previous set of imported systems, with average response times slower by about 15%, especially noticeable delays in large-scale parallel computing tasks." Ruixing's chief engineer Chen Zhi candidly points out the shortcomings.
"No problem." Yang Ping isn't concerned with these, "A slight delay isn't scary; the scary part is having someone choke you at a critical moment, locking the system, wiping the data. What we need to do now is to march to our own beat on this track that belongs to us, continuously debugging, optimizing, iterating. Today it's 15% slower; next version could be 10%. The version after, we might even catch up or surpass."
He walks to a domestic new high-throughput sequencer, his palm lightly resting on its cool metal shell, as if feeling its internal chip's pulse: "It may be temporarily behind now, but every line of code, every hardware interface is completely open to us. We can delve into the depths, remodeling it according to our specific needs, optimizing it, even sacrifice some generality for extreme performance for particular experimental purposes. This kind of complete autonomy is something that no high performance parameter can replace."
"Professor Yang, you really have foresight to contemplate today's challenges in the design phase of these major projects, allowing the research to be compatible with temporarily lagging domestic equipment, otherwise several major projects would have been aborted."
Tang Shun now finally understands why, when Yang Ping designed the projects, he could have been bolder, tapping into the maximum performance of the equipment but didn't. His designs utilized only 90% of the equipment parameters, some even just 80%. If he had extracted maximum parameters, compatibility would have been impossible, and all projects would've waited on equipment, a wait uncertain for years.
It was precisely this advanced vision and deep crisis awareness that allowed Sanbo Laboratory's other critical projects to endure a brief transition pain but miraculously avoided severe harm or stagnation when BG Group began its technological blockade.
At the blockade's onset, anxiety and unrest did permeate the laboratory. Several stem cell culture and differentiation tests highly relying on imported special serums, specific model cytokines, and precision consumables were first to flash red, risking project interruption.
At the time, Yang Ping did not hesitate much, directly gathering all core team members to study a "rail switch" for the experiments. Some maladjustments appeared during the process due to data fluctuations stemming from equipment precision and reagent batch differences, which were normal. After some adaptation and adjustments, the experiments quickly ran on new "tracks."
For some stem cell manipulation steps requiring extreme precision, researchers leveraged profound understanding of experimental principles and keen cell state observations, manually tweaking cultivation environment parameters and optimizing techniques, thereby overcoming the new equipment interface's cumbersome interaction and feedback system.
Within barely a week, the stem cell project's crucial "mesenchymal stem cells directional differentiation to precursor cells" induction experiment was successfully replicated in new, fully domestically produced bioreactors and large-capacity temperature control systems, with microscopic observations and subsequent immunofluorescence identification data curves matching results previously obtained using imported equipment, key index deviation controlling within permissible scope.
If you find any errors ( broken links, non-standard content, etc.. ), Please let us know < report chapter > so we can fix it as soon as possible.